Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3913]

Future directions in glioblastoma: the potential role of TKIs

Prof Roger Stupp, Dr Giuseppe Lombardi

Future directions in glioblastoma: the potential role of TKIs ( Prof Roger Stupp, Dr Giuseppe Lombardi )

Pre-operative radiation for pancreatic cancer

Prof Sunil Krishnan - MD Anderson Cancer Center, Houston, USA

Pre-operative radiation for pancreatic cancer ( Prof Sunil Krishnan - MD Anderson Cancer Center, Houston, USA )

Second-line and beyond in mCRC: Optimising the benefit and reducing the risk

Prof Mohamed Salem - Georgetown University Hospital, Washington D.C., USA

Second-line and beyond in mCRC: Optimising the benefit and reducing the risk ( Prof Mohamed Salem - Georgetown University Hospital, Washington D.C., USA )

Controversies in the management of prostate cancer

Prof Mach Roach III - University of California, San Francisco, USA

Controversies in the management of prostate cancer ( Prof Mach Roach III - University of California, San Francisco, USA )

Local treatment in oligometastatic prostate cancer: Radiotherapy

Prof Mach Roach III - University of California, San Francisco, USA

Local treatment in oligometastatic prostate cancer: Radiotherapy ( Prof Mach Roach III - University of California, San Francisco, USA )

SBRT photons, protons or carbon for prostate cancer: How good is the data?

Prof Mach Roach III - University of California, San Francisco, USA

SBRT photons, protons or carbon for prostate cancer: How good is the data? ( Prof Mach Roach III - University of California, San Francisco, USA )

Optimum duration of adjuvant treatment of stage III colorectal cancer: 3 versus...

Prof John Marshall - Georgetown University Hospital, Washington D.C., USA

Optimum duration of adjuvant treatment of stage III colorectal cancer: 3 versus 6 months ( Prof John Marshall - Georgetown University Hospital, Washington D.C., USA )

Colorectal cancer in the young: What do we know and what can we do?

Prof John Marshall - Georgetown University Hospital, Washington D.C., USA

Colorectal cancer in the young: What do we know and what can we do? ( Prof John Marshall - Georgetown University Hospital, Washington D.C., USA )

Rectal cancers: Positioning of watchful waiting and minimally invasive...

Prof Henk Wegstapel - Canterbury Christ Church University, Canterbury, UK

Rectal cancers: Positioning of watchful waiting and minimally invasive procedures ( Prof Henk Wegstapel - Canterbury Christ Church University, Canterbury, UK )

Beyond second-line therapy: New hope for mCRC patients in Egypt

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

Beyond second-line therapy: New hope for mCRC patients in Egypt ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

Multi-target kinase inhibitors: From data to practice

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

Multi-target kinase inhibitors: From data to practice ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

Using genetic testing to tailor chemotherapy

Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA

Using genetic testing to tailor chemotherapy ( Prof Heinz-Josef Lenz - USC Norris Comprehensive Cancer Center, Los Angeles, USA )

More from ecancer